Please provide your email address to receive an email when new articles are posted on . 10.5% of patients treated with isotretinoin experienced mood changes. 88% of patients experienced symptom ...

Discover a study revealing how prebiotics improve acne vulgaris by balancing the skin microbiome and enhancing collagen for ...

The first-in-class topical acne treatment targets the androgen receptor. The Food and Drug Administration (FDA) has approved Winlevi® (clascoterone cream 1%; Cassiopea) for the topical treatment of ...

This article was reviewed by Felix Gussone, MD. Understanding the Testosterone-Acne Connection If you thought acne breakouts ...

Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical ...

Twyneo is an investigational, fixed-dose combination of tretinoin 0.1%, a retinoid, and benzoyl peroxide 3%, a topical antibacterial. The Food and Drug Administration (FDA) has accepted for filing the ...

The trial was conducted by Sagimet’s license partner for China, Ascletis Bioscience Co., in 480 patients with moderate to ...

Acne vulgaris on the back of a healthy 13-year-old boy A dermatologist explores dealing with increasing bacterial resistance and selecting the treatment that minimizes irritation and other skin ...

Patient-reported outcome (PRO) measures were included in approximately one-half of acne vulgaris and rosacea randomized controlled trials, despite their utility in capturing the patient perspective.

Please provide your email address to receive an email when new articles are posted on . Acne vulgaris may be driven by underlying systemic, immune-inflammatory pathways. Addressing those underlying ...

Subject of the leading article in last week’s American Medical Association Journal was acne vulgaris—the blackheads and pimples of adolescence. Dr. Jeffrey Charles Michael, Houston acne specialist who ...

Combined therapies have emerged as the key strategy in reducing the presence of resistant bacteria, while increasing the efficacy of treatment. Concomitant use of nonantibiotic therapies such as ...